NPS Pharmaceuticals (NASDAQ:NPSP) is a company whose shares are active, trading 1.6% higher to $7.68. The S&P is currently trading fractionally lower to 1,515 and the Dow Jones Industrial Average is trading fractionally lower to 14,055.
Over the past year, NPS Pharmaceuticals has traded in a range of $6.30 to $11.22 and is now at $7.68, 22% above that low. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 1.4%.
There is potential upside of 114.3% for shares of NPS Pharmaceuticals based on a current price of $7.68 and an average consensus analyst price target of $16.45. The stock should run into initial resistance at its 200-day moving average (MA) of $8.55 and subsequent resistance at its 50-day MA of $8.75.
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.